Onyia Jude bought NBIX
June 1, 2026 · Form 4 insider transaction
Onyia Jude bought 11,000 shares of Neurocrine Biosciences, Inc. at $84.74 per share, a transaction worth $932.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,000
Price
$84.74
Total value
$932.1K
InsiderOnyia Jude
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after36,846
OwnershipDirect
10b5-1 planNo
AmendedNo